Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.
Published February 13, 2013 · Recall initiated: January 30, 2013
Summary
FDA records drug Class II recall D-147-2013, published February 13, 2013 and initiated January 30, 2013. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 1,894 bottles; Lot: Lot #: 1110829, Exp 05/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if LANSOPRAZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LANSOPRAZOLE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide
- UPC
- 0303788030932
- Lot
- Lot #: 1110829, Exp 05/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs ofAugust 3, 2022
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs ofAugust 3, 2022
- FDALansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 TabletsMay 11, 2022
- FDALansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy'sApril 6, 2022
- FDAEstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physicianFebruary 13, 2013
- FDASLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumulated and DistributedFebruary 13, 2013
Questions about this recall
Was Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05. recalled?
Yes. FDA published recall D-147-2013 on February 13, 2013. Reported hazard: Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LANSOPRAZOLE. UPC: 0303788030932.